Quest Diagnostics Aktie
| 211,90USD | 0,75USD | 0,36% |
WKN: 904533 / ISIN: US74834L1008
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 49 000 | 49 000 | 48 000 | 56 000 | 57 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,20 | 0,19 | 0,18 | 0,19 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 2 741 | 1 898 | 2 372 | 2 392 | 2 378 |
| Summe Anlagevermögen | 10 870 | 10 939 | 11 650 | 13 761 | 13 847 |
| Summe Aktiva | 13 611 | 12 837 | 14 022 | 16 153 | 16 225 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 049 | 6 830 | 7 604 | 9 257 | 8 939 |
| Summe Eigenkapital | 6 562 | 6 007 | 6 418 | 6 896 | 7 286 |
| Summe Passiva | 13 611 | 12 837 | 14 022 | 16 153 | 16 225 |
Adresse
| 500 Plaza Drive, 07940 Secaucus | |
| Telefon | +1 (973) 520-2700 |
| Internet | http://www.questdiagnostics.com |
Management
|
Adrienne L. Brott
Chief Quality & Regulatory Affairs Officer, SVP |
|
Alyssa Waxenberg
Senior Director-Patient Digital Products |
|
Benjamin Beauvalot
Senior VP, Chief Strategy & M&A Officer |
|
Catherine T. Doherty
Executive Vice President-Regional Businesses |
|
Cecilia K. McKenney
Chief Human Resources Officer & Senior VP |
|
Darren Wheeler
Vice President-Pathology & Medical Services |
|
Denise M. Morrison
Independent Director |
|
Dermot Victor Shorten
Senior Vice President-Ventures, Strategy, M&A |
|
Doug Lang
Director-Technical Products |
|
Garry Clark
Chief Marketing & Communications Officer, SVP |
|
Gary M. Pfeiffer
Independent Director |
|
James E. Davis
Chairman, President & Chief Executive Officer |
|
Karthik Kuppusamy
Senior Vice President-Clinical Solutions |
|
Kristin Wallace
Chief Compliance Officer & Senior Vice President |
|
Luis A. Diaz
Independent Director |
|
Mark E. Delaney
Chief Commercial Officer & Senior Vice President |
|
Mark Gardner
Senior Vice President-Oncology & Genomics |
|
Michael E. Prevoznik
Senior Vice President & General Counsel |
|
Michael Joseph Deppe
Chief Accounting Officer, SVP & Controller |
|
Murali Balakumar
Chief Information & Digital Officer, Senior VP |
|
Patrick Plewman
Senior Vice President-Diagnostic Services |
|
Robert B. Carter
Independent Director |
|
Sam A. Samad
Chief Financial Officer & Executive Vice President |
|
Sean D. Mersten
Secretary & Vice President |
|
Shawn Bevec
Vice President-Investor Relations |
|
Timothy L. Main
Independent Director |
|
Timothy M. Ring
Lead Independent Director |
|
Tracey C. Doi
Independent Director |
|
Tracy L. Cinco-Abela
Treasurer & Vice President |
|
Vicky B. Gregg
Independent Director |
|
Wright L. Lassiter
Independent Director |
|
Yuri A. Fesko
Chief Medical Officer & Senior Vice President |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.